Tocilizumab may be a potential addition to our weapons against neuro-Behçet's disease

Med Hypotheses. 2008;71(1):156-7. doi: 10.1016/j.mehy.2008.01.011. Epub 2008 Mar 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Behcet Syndrome / immunology
  • Behcet Syndrome / therapy*
  • Humans
  • Models, Neurological
  • Nervous System Diseases / immunology
  • Nervous System Diseases / therapy*
  • Receptors, Interleukin-6 / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Receptors, Interleukin-6
  • tocilizumab